A Single Institution's 10 Year Experience of Treating High Grade Superficial Transitional Cell Carcinoma and Carcinoma In Situ of the Bladder with Intravesical BCG

By Meyer Jon-Paul   Persad Rajendra   Gillatt David A.  

UroOncology, Vol. 2, Iss. 4, 2002-01 ,pp. : 189-191

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Use of BCG in Immunotherapy of Superficial Bladder Cancer: Multicentric Investigation on Safety and Compliance

By Morgia Giuseppe   Falsaperla Mario   Madonia Massimo   Vacirca Franco   La Pira Giuseppe   De Grande Gaetano   Nicololosi Dario   Raciti Giovanni   Capizzi Giuseppe   Serrao Antonio   Torrisi Benedetto  

UroOncology, Vol. 2, Iss. 3, 2003-07 ,pp. : 129-135

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intravesical valrubicin in the treatment of carcinoma in situ of the bladder

By Steinberg GD   Kuznetsov DD   O’Connor RC   Alsikafi NF  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1009-1013

Informa Healthcare

Access to resources Recommend Favorite

The Effect of BCG on Angiogenesis and Cellular Proliferation in Recurrent Superficial TCC of the Bladder

By Pareek Gyan   Shevchuk Maria   Armenakas Noel A.   Budak Mehmet   Fracchia John A.  

UroOncology, Vol. 4, Iss. 1, 2004-03 ,pp. : 31-34

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intravesical Therapy of Superficial Bladder Cancer

By  

Current Pharmaceutical Design, Vol. 6, Iss. 3, 2000-02 ,pp. : 345-359

Bentham Science Publishers

Access to resources Recommend Favorite